Effective immuno-therapeutic treatment of Canine Leishmaniasis.
BackgroundCanine Leishmaniasis (CanL) caused by the L.infantum species is one of the biggest threats to the health of the South American canine population.Chemotherapeutics currently used for the treatment of CanL fail to induce a total parasite clearance while inducing numerous side effects.As CanL is an immunomodulated disease, the use of immuno-